As GLP-1 medications such as Ozempic, Mounjaro and Wegovy rise in popularity, so do concerns over their side effects.
Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...
From lemon coffee to oatzempic, there's always a new weight loss hack people are buzzing about. The latest of these is ...
The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.
Two Omaha women lost more than 300 lbs. combined with injections of a GLP-1 drug, which are used increasingly for weight loss ...
A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...
American doctors, who tracked over 37 million people, said the injections put users at higher risk of nonarteritic ischemic ...
Ozempic may also help people drink less alcohol. Primary care doctors are concerned about patients accessing GLP-1s through ...
Six percent of Americans have used Ozempic, Wegovy and similar drugs. They’re unwitting experimental subjects.
In a world where alcohol claims nearly 178,000 lives annually in the U.S. alone, a glimmer of hope has emerged from an ...
The government-funded study was small and experts say it's not yet clear how safe these drugs are for people who don't need ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results